Skip to content
MedsAcross

Brand family

Zydelig

Idelalisib · Gilead Sciences
United States
Presentations
2
Markets
1

Zydelig is a brand of Idelalisib marketed by Gilead Sciences, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Idelalisib
Brand owner
Gilead Sciences
Registered in
United States
Strengths and forms
100 mg tablet, 150 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Zydelig 100 mg tabletOralGilead SciencesUS FDAAvailable on request
Zydelig 150 mg tabletOralGilead SciencesUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Zydelig

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.